Hi [[ session.user.profile.firstName ]]

NGS: New Business Models in Diagnostics and Drug Development

Next-generation sequencing (NGS) has emerged as a key technology to deliver the next level of healthcare solutions. While the $1,000 genome was achieved in 2015, Frost & Sullivan predicts the $100 genome to be possible by 2024. The significant dip in cost of extracting genetic data has led to the creation of massive genomic data volumes that are expected to be some of the largest data sets globally by 2025, exceeding data generated by YouTube and Twitter.
Recorded Aug 9 2017 58 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Frost & Sullivan Transformational Health Team, Dr. Misha Kapushesky,Genestack CEO and Dr. Elia Stupka,Boehringer Ingelheim
Presentation preview: NGS: New Business Models in Diagnostics and Drug Development

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • The Impact of Artificial Intelligence in Medical Imaging Aug 9 2018 3:00 pm UTC 60 mins
    Nadim Daher,Industry Principal, Siddharth Shah, Industry Analyst, Frost & Sullivan
    Medical imaging has become a leader for the application of artificial intelligence technologies in the healthcare space, especially recently with deep learning techniques. This is evident from the fact that over 90 companies have set out to develop and commercialize AI-based solutions for the medical imaging industry. The number continues to grow as new start-ups emerge, as incumbents develop native AI solutions, and as tech companies move into the field, creating a highly dynamic ecosystem. With various countries edging past the innovator adoption phase and into the early adopter one, the time is now for stakeholders to refine and test their value proposition, partnership approach, and go-to-market strategies.

    Key Takeaways:
    • How far we have reached over the past five years and the current lay of the land
    • Where we are headed over the next five years and the direction of industry progress
    • Deep-dive into the opportunity for automation, acceleration and augmentation of medical image analysis
    • Anticipate the advent of intelligent medical imaging machines with embedded AI
  • Digital Therapeutics: Trends and Growth Opportunities Recorded: Jun 26 2018 61 mins
    Frost & Sullivan's Global Digital Health Team, Wolf Shlagman CEO - Care Angel, Amer Haider CEO - Doctella
    Digital therapeutics presents a significant opportunity for traditional pharmaceutical therapeutics and information technology (IT) capabilities to influence a new approach to increase positive patient outcomes while reducing the overall cost of healthcare.

    Key Takeaways:
    · Gain expert insight into the accurate definition of digital therapeutics and market participants.
    · Learn about new solutions from mHealth companies that will combine apps, patient education, professional intervention and peer support to increase patient engagement and medication adherence by augmenting or replacing traditional drug therapeutics.
    · Hear opportunities to utilize digital therapeutics to improve medical workflow and patient communications.
    · Learn about some of the critical milestones related to digital therapeutics.
  • The Rise of Digital Enterprise: Growth Strategies for Healthcare Companies Recorded: May 31 2018 59 mins
    Nitin Naik, Slava Akmaev Chief Analytics Officer, BERG, Guillaume Kerboul, Dassault Systemes; Dr. Thorsten Harzer, QIAGEN
    Digital Transformation is powering growth opportunities in Smart R&D, Patient Engagement, and Healthcare eCommerce. The explosion of patient centricity and technological advancement in big data analytics, cloud and artificial intelligence are putting severe pressures on companies to leverage all types of data (clinical, social media, IOT, etc.) in innovative ways. While the industry is decidedly upbeat on this new trajectory, there are heightened concerns about managing data privacy, especially for data flows outside the traditional ecosystem.

    Key Takeaways:
    • Learn about trends and growth opportunities in the Life sciences IT sector
    • Discuss hot topics, including Smart R&D, Digital Manufacturing, Connected patient and IVD eCommerce (B2C models)
    • Hear from industry leaders about company growth strategies and best practices for implementing digital solutions
    • Gain perspectives on M&A’s and the impact of investments from Big Tech companies
  • Everything You Need to Know About Critical Healthcare Segments Recorded: Feb 27 2018 67 mins
    Sanjeev Kumar (Industry Manager), Natasha Gulati (Industry Manager), Siddharth Shah (Industry Analyst)
    Frost & Sullivan is forecasting another year of disruptions in critical healthcare segments such as diabetes care, smart hospitals, healthcare cloud computing and digital pathology. This webinar will focus on these industries along with insights on key trends influencing the healthcare system, followed by a live question-and-answer session.

    Join Us to Gain Insights on:

    • Future paradigms in diabetes care and harnessing evolutionary trends to improve the quality of life for diabetics
    • Understanding the smart hospital concept and identifying relevant applications and growth opportunities
    • Healthcare cloud computing trends, such as global provider spending on cloud solutions approaching $10 billion by 2021
    • Growth opportunities in the global digital pathology market
  • 2018 Frost & Sullivan Predictions and Outlook for Digital Health Recorded: Feb 22 2018 51 mins
    Daniel Ruppar, Global Program Director, Analysts from Frost & Sullivan's Global Digital Health Team
    Expert Insights You Will Not Want to Miss:

    • Hear market predictions from world-renowned analysts
    • Learn areas of growth and controversy for 2018 in digital health and health IT
    • Discussions on hot areas including AI, Digital Therapeutics and Blockchain
    • Movements of major ICT and Technology companies in their Healthcare strategy
    • Understand the critical vendors to watch for this year
  • The Picture Perfect Future of the US Medical Imaging Industry Recorded: Jan 23 2018 62 mins
    Frost & Sullivan Transformational Health Team, Shannon Werb, vRad
    The US medical imaging industry is transforming to cope with the challenges of the present and the demands of the future. The current care provision landscape is highly fragmented, and a coherent strategy is required to enhance interoperability among stakeholders across the imaging ecosystem. Stakeholders across the industry must also come together to eliminate redundancies and duplications, and streamline the imaging process, to improve the patient experience.
  • 2018 Global Healthcare Market Predictions Revealed Recorded: Dec 13 2017 60 mins
    Reenita Das, Partner, Kamaljit Behera, Industry Analyst, Neil Jordan, Microsoft, Kay Eron, Intel, Keith Bigelow,GE Healthcare
    2018 will be a tipping point for mainstream adoption of popular digital health technology solutions such as artificial intelligence, mHealth/wearables, telehealth, Big Data analytics, and robotics. The transition of technologies from ideation to actionable applications will drive new opportunities across the globe.

    From data monetization unleashing the power of patient data to digital transformation of patient monitoring, there will be growing awareness of current inefficiencies and new opportunities identified to improve the efficiency of healthcare delivery.
  • R&D Investments and Digitization Propel Growth of Diagnostic Solutions in Asia Recorded: Dec 6 2017 58 mins
    Rhenu Bhuller, Partner & Sanjeev Kumar, Industry Manager (Frost & Sullivan), Dr. Allen Lai, SVP of ACT Genomics Singapore
    The industry is being disrupted by integration of the multi-disciplinary capabilities in biology, chemistry and computational power that companies can leverage to develop new solutions to diagnose, treat and manage chronic disease conditions, such as cancer, cardiovascular disease and diabetes. There is immense pressure on companies to build competencies in product development, manufacturing and distribution of new technology platforms such as point-of-care molecular diagnostics to capture new growth opportunities in the precision medicine market—a paradigm shift that will transform clinical practice and treatment outcomes.
  • Healthcare's Challenges with Blockchain - A Promising but Bumpy Ride! Recorded: Oct 3 2017 57 mins
    Reenita Das, Partner, Kamaljit Behera, Frost & Sullivan, IOTA Foundation, Hashed Health, Healthchain
    We invite you to join Frost & Sullivan’s Transformational Healthcare team and industry experts to discuss blockchain technology with the most potential applications across the healthcare industry, including data interoperability, cybersecurity, insurance fraud management, and drug supply chain provenance. Learn how to differentiate the hype from reality and hear key strategic considerations for future success.
  • Digital Health Markets Update: From AI to Zzzs - What Comes Next? Recorded: Aug 29 2017 53 mins
    Daniel Ruppar, Global Program Director - Digital Health
    Digital health brings a diverse range of growth opportunities for vendors across the value chain. As the space evolves we have experienced a multitude of stepwise successes and stellar failures, yet funding continues to flood the sector. Major moves continue to come into the industry from the broader vendor environment, underlining the importance of health in everyone’s lives and progressively in strategic interests of the C-Suite across the ecosystem. Join Frost & Sullivan in this webinar update showcasing different facets of the market, and learn why there’s something for everyone in digital health.
  • NGS: New Business Models in Diagnostics and Drug Development Recorded: Aug 9 2017 58 mins
    Frost & Sullivan Transformational Health Team, Dr. Misha Kapushesky,Genestack CEO and Dr. Elia Stupka,Boehringer Ingelheim
    Next-generation sequencing (NGS) has emerged as a key technology to deliver the next level of healthcare solutions. While the $1,000 genome was achieved in 2015, Frost & Sullivan predicts the $100 genome to be possible by 2024. The significant dip in cost of extracting genetic data has led to the creation of massive genomic data volumes that are expected to be some of the largest data sets globally by 2025, exceeding data generated by YouTube and Twitter.
  • Beyond Superior Care Quality—How Can APAC Hospitals Become Truly Patient Centric Recorded: Jul 26 2017 61 mins
    Frost & Sullivan, Gabe Rjipma,Microsoft, Dr. Timothy Low, Farrer Park Hospital, David Vu, GE Healthcare Asia-Pacific
    Hospital information technology (Hospital IT) spending in Asia-Pacific (APAC) will grow at a compound annual growth rate of 9.7% between 2016 and 2021 to reach an estimated end-stage market size of more than $15 billion. Key growth opportunities in the region include solutions for Healthcare Data Continuity, Patient Engagement & Experience, Healthcare Cloud, Big Data & Analytics, and Healthcare Cybersecurity. However, the identification of these growth opportunities is only the first step toward succeeding as an ICT vendor in this market. The real demystification lies in understanding very specific target customer needs and then building a value proposition and business model that addresses those needs.
  • 2017 Frost & Sullivan Predictions in Diagnostics Recorded: Mar 23 2017 64 mins
    Transformational Health Team, Harry Glorikian, Board Advisor and Eunice Teo, Director, Business Development, QuantuMDx
    The global clinical diagnostics industry is undergoing a transformation propelled by laboratory consolidation and automation, an enormous move toward data-driven healthcare, large investments in unifying technologies, and renewed business models driven by products and value-added services. There is immense pressure on companies to radically improve new product innovation, manufacturing, and distribution of technologies such as point-of-care molecular diagnostics to capture new growth opportunities in the precision medicine market.
  • 2017 Frost & Sullivan Predictions in Digital Health Recorded: Jan 31 2017 59 mins
    Digital Health Team: Daniel Ruppar, Nancy Fabozzi and Victor Camlek
    Over the past decade, the adoption of digital solutions has increased significantly throughout the healthcare industry. This exceptionally strong growth trajectory is expected to continue into the foreseeable future as U.S. healthcare organizations transform to meet the demand for more efficient, clinically integrated and decentralized care systems that serve empowered, technologically-savvy consumers who strongly value convenience and personalization.
  • Billion-dollar Growth Opportunities in the Global Healthcare Industry by 2025 Recorded: Jan 25 2017 59 mins
    Visionary Healthcare Team: Venkat Rajan and Siddharth Shah
    The healthcare industry is undergoing rapid transformation. By 2025, the healthcare ecosystem is expected to look drastically different from today. In 2025, global trends of aging populations, rising chronic disease prevalence and urbanization are bound to further strain healthcare systems already grappling with issues of healthcare access, quality, and cost. In response, new business models are expected to emerge to address the needs of the future. In order to make the most gains, stakeholders must successfully leverage this transformation.
  • Disruptive Technologies and Emerging Trends Drive Life Science Transformation Recorded: Jul 7 2016 55 mins
    Transformational Health Team: Nitin Naik, Divyaa Ravishankar, Christi Bird, and Unmesh Lal
    The global pharmaceutical industry is witnessing an unprecedented era. Several new demand spaces such as innovative therapeutics (immuno-oncology), clinical diagnostics (liquid biopsy), and research tools (next-generation sequencing) have emerged, driving companies to sharpen their long-term positions. Fundamental behavioral shifts in these spaces are redefining the market. Companies are adopting a “beyond-the-pill” approach and increasing investments in innovations related to drug discovery, clinical trials, supply-chain solutions, and patient engagement. This briefing reviews recent industry transformations, changes in business models, growth opportunities, and key predictions for the life sciences industry.
  • Care Delivery Transformation Through Telehealth – Growth Opportunities in APAC Recorded: May 25 2016 51 mins
    Natasha Gulati, Kiranjit Kaur
    Demand for telehealth is on the rise in APAC as healthcare industry stakeholders across the region seek to address challenges of an ageing population and rising healthcare costs. However, market sustainability heavily depends on the establishment of successful business models that provide holistic health and wellness solutions by creating an ecosystem of products and services. In this briefing we will discuss the APAC Telehealth market opportunity with in-depth analysis of technologies, regulations, industry partnerships and business models that will help shape the future of care delivery in the region.
  • Moving Beyond Fitness - Clinical Grade Wearables Poised to Transform Healthcare Recorded: Apr 12 2016 60 mins
    Rhenu Bhuller, Venkat Rajan,Kamaljit Behera - Frost & Sullivan
    Industry convergence and technological innovations are giving rise to a new breed of wearable technologies that are capable of meeting the unique needs and requirements of clinical care settings. Unlike more prevalent general health and fitness devices, these wearables can function with higher levels of accuracy and reliability allowing them to be used by medical professionals to make assessments and recommendations for patients.

    In this interactive briefing, Frost & Sullivan’s Transformational Health team will explore the future applications and opportunities for these innovations, and key strategy considerations for developers.

    Join us as we discuss these and other key topics.
  • Latin American Electronic Medical Record Market Analysis Recorded: Mar 26 2013 24 mins
    Federico Baguear, Latin America Healthcare Industry Analyst
    This briefing will investigate how regulations and hospital needs stimulate the EMR market in Latin America and will specially focus on how these regulations will potentially encourage the EMR implementation until 2017.

    Why You Should Attend:
    ·Learn about the market dynamics of EMR in the region
    ·Identify the drivers and restraints impacting the EMR market for the next six years
    ·Discover business opportunities
Frost & Sullivan GIL Webcast Series
Our Healthcare webcasts cover Connected Health, Life Sciences and Advanced Medical Technologies to help you to better understand buyer-seller dynamics as the healthcare system transitions to digital information, the pace at which new and innovative medical devices and systems are being adopted and getting embedded into the typical clinical pathway, both in mature and emerging markets, and enables you to bring clarity to pharmaceutical/biotechnology, in-vitro diagnostics and life science research tools market decisions and implementation tactics.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: NGS: New Business Models in Diagnostics and Drug Development
  • Live at: Aug 9 2017 3:00 pm
  • Presented by: Frost & Sullivan Transformational Health Team, Dr. Misha Kapushesky,Genestack CEO and Dr. Elia Stupka,Boehringer Ingelheim
  • From:
Your email has been sent.
or close